Effect of tauroursodeoxycholic acid on serum liver enzymes and dyspeptic symptoms in patients with chronic active hepatitis
✍ Scribed by P. Portincasa; V. Palmieri; F. Doronzo; G. Vendemiale; E. Altomare; C. Sabbà; G. Palasciano; O. Albano
- Book ID
- 117090741
- Publisher
- Elsevier Science
- Year
- 1993
- Tongue
- English
- Weight
- 702 KB
- Volume
- 53
- Category
- Article
- ISSN
- 0011-393X
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
The effects of ursodeoxycholic acid (UDCA, 450 mg daily) in patients with histologically proven chronic active hepatitis (CAH) have been evaluated in a randomized, double-blind, placebo-controlled study. Twenty-six patients with serum alanine aminotransferase (ALT) values at least twice the normal u
The effect of ursodeoxycholic acid administration on liver function tests and on bile acid metabolism was investigated in 18 patients with chronic active hepatitis. Three different doses of ursodeoxycholic acid-250 mg, 500 mg and 750 mg-were administered daily to each patient for consecutive 2-mo pe